Lung Cancer Diagnosis & Treatment Market Size, Share and Forecast 2021-2027

The global lung cancer diagnosis & treatment market is anticipated to grow at a CAGR of around 7.2% during the forecast period (2021-2027). The factor augmenting the growth of the global lung cancer diagnosis & treatment market include the rising prevalence of lung cancer due to the high consumption of cigarettes and alcohol. According to the American Cancer Society Journals, in 2019, there were 1,762,450 new cancer cases diagnosed and 606,880 cancer mortalities in the US registered. The rising US FDA approvals for the drugs produced by the key market players have a positive impact on the growth of the market. 

To Request a Sample of our Report on Lung Cancer Diagnosis & Treatment Market:  https://www.omrglobal.com/request-sample/lung-cancer-diagnostics-treatment-market

·         In May 2020, the US FDA approved the Opdivo (nivolumab) + Yervoy (ipilimumab) combined with limited chemotherapy as the first-line treatment of metastatic or recurrent non-small cell lung cancer. 

·         In May 2020, Eli Lilly and Company announced that the US FDA has approved its CYRAMZA drug in combination with erlotinib, for the first-line treatment of people with metastatic non-small cell lung cancer (NSCLC). The company also got approval for the Retevmo (selpercatinib) drug for the treatment of advanced RET-driven lung cancer on the same date.

·         In May 2020, The US FDA approved atezolizumab drug for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC). The drug is produced by Genentech Inc, a subsidiary of Roche.

·         In May 2020, Tabrecta (capmatinib, formerly INC280), an oral MET inhibitor for adult patients with metastatic non-small cell lung cancer (NSCLC), produced by Novartis AG has been approved by the US FDA.

·         Thus these approvals for the drugs can be expected to drive the market. Moreover, the government initiative programs to spread awareness for lung cancer and treatments has a positive influence on the market growth. 

Market Coverage

·         The market number available for – 2020-2027

·         Base year- 2020

·         Forecast period- 2021-2027

Segment Covered- 

·         By Type

·         By Treatment

·         By Diagnosis

Regions Covered-

·         North America

·         Europe

·         Asia-Pacific

·         Rest of the World

·         Competitive Landscape- F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Co., Pfizer Inc., Sanofi S.A., Eli Lilly and Co., Merck & Co. Inc., Novartis AG, AstraZeneca Plc, GlaxoSmithKline plc., among others.

 (Get 15% Discount on Buying this Report)

A full Report of Lung Cancer Diagnosis & Treatment Market is Available at:  https://www.omrglobal.com/industry-reports/lung-cancer-diagnostics-treatment-market

Global Lung Cancer Diagnosis & Treatment Market Report Segment

By Type

·         Non-Small Cell Lung Cancer

·         Small Cell Lung Cancer

By Treatment

·         Chemotherapy

·         Targeted Therapy

·         Immunotherapy

·         Radiation Therapy

·         Others

By Diagnosis

·         Ct Scan

·         X-Rays

·         Lung Cancer Screening

·         Needle Biopsy

·         Others (Bronchoscopy, Sputum Cytology)

Global Lung Cancer Diagnosis & Treatment Market Report Segment by Region

North America

·         United States

·         Canada

Europe

·         UK

·         Germany

·         Spain

·         France

·         Italy

·         Rest of Europe

Asia-Pacific

·                     India

·                     China

·                     Japan

·                     South Korea

·                     Rest of APAC

Rest of the World

·                     Latin America 

·                     Middle East & Africa

Company Profiles 

·         AbbVie Inc.

·         AstraZeneca Plc

·         Bayer AG

·         Boehringer Ingelheim International GmbH

·         Bristol-Myers Squibb Co.

·         Daiichi Sankyo Co, Ltd.

·         Eisai Co., Ltd.

·         Eli Lilly and Co.

·         GlaxoSmithKline plc.

·         Merck & Co., Inc.,

·         Myriad Genetics, Inc.

·         Novartis International AG

·         Pfizer Inc.

·         F. Hoffmann-La Roche Ltd

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/lung-cancer-diagnostics-treatment-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

 


Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more